WASHINGTON — Public health officials across the United States are continuing to monitor the effects of recent federal vaccine policy changes on immunization programs, disease surveillance and public confidence, as legal challenges and state-level responses keep the nation's vaccination landscape in flux.
Federal health policy has undergone significant changes since early 2026, including revisions to recommended childhood immunization schedules and executive actions directing federal agencies to review vaccine recommendations. In May, President Donald Trump signed an executive order instructing the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP) to evaluate childhood vaccine recommendations using a Department of Health and Human Services assessment comparing U.S. practices with those of other developed countries.
The administration has said the changes are intended to align recommendations with international practices while preserving access to vaccines and providing greater flexibility for parents and physicians. The White House has also said insurance coverage and federally supported vaccine programs should continue to reflect CDC recommendations adopted following the review.
Medical organizations and public health experts have expressed concern that changes to longstanding recommendations could reduce vaccination uptake and complicate public messaging. Several professional groups and state governments have challenged aspects of the policy in federal court, arguing that the revisions departed from established scientific review processes. Some court actions have temporarily halted portions of the federal changes while litigation proceeds.
At the same time, state health departments have continued to respond to outbreaks of vaccine-preventable diseases. Health officials have reported rising measles cases in multiple states during 2026, with the overwhelming majority occurring among people who were unvaccinated or whose vaccination status was unknown, according to public health authorities cited by multiple news organizations. Experts have said maintaining high vaccination coverage remains critical to limiting transmission.
The evolving policy environment has also prompted responses from the private sector. AHIP, the U.S. health insurance industry's trade association, announced that participating insurers would continue covering routine childhood vaccinations through 2027, a move public health specialists said could help maintain access to recommended immunizations while federal policy reviews continue.
Federal officials have maintained that their review is intended to ensure vaccine recommendations reflect current scientific evidence, while public health organizations continue to emphasize the importance of established immunization programs in preventing infectious disease.
Court proceedings over several vaccine-related policies remain ongoing, and federal health agencies are expected to continue reviewing immunization recommendations under the framework established by the administration.
